Liraglutide alleviates experimental diabetic cardiomyopathy in a PDH-dependent manner.
Saved in:
| Title: | Liraglutide alleviates experimental diabetic cardiomyopathy in a PDH-dependent manner. |
|---|---|
| Authors: | Chan JSF; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.; Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada., Greenwell AA; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.; Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada., Saed CT; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.; Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada., Stenlund MJ; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.; Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada., Mangra-Bala IA; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.; Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada., Tabatabaei Dakhili SA; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.; Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada., Yang K; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.; Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada., Ferrari SR; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.; Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada., Eaton F; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.; Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada., Gopal K; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.; Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada., Ussher JR; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.; Cardiovascular Research Institute, University of Alberta, Edmonton, Alberta, Canada. |
| Source: | The Journal of endocrinology [J Endocrinol] 2024 Jul 08; Vol. 262 (2). Date of Electronic Publication: 2024 Jul 08 (Print Publication: 2024). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioScientifica Country of Publication: England NLM ID: 0375363 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1479-6805 (Electronic) Linking ISSN: 00220795 NLM ISO Abbreviation: J Endocrinol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
